Literature DB >> 28848002

In Vitro Interactions of Echinocandins with Triazoles against Multidrug-Resistant Candida auris.

Hamed Fakhim1,2, Anuradha Chowdhary3, Anupam Prakash3, Afsane Vaezi4, Eric Dannaoui5, Jacques F Meis6,7, Hamid Badali8,9.   

Abstract

We determined the in vitro interactions between echinocandins and azoles against 10 multidrug-resistant Candida auris strains by use of a microdilution checkerboard technique. Our results suggest synergistic interactions between micafungin and voriconazole with fractional inhibitory concentration index (FICI) values of 0.15 to 0.5, and we observed indifferent interactions when micafungin was combined with fluconazole (FICI, 0.62 to 1.5). Combinations of caspofungin with fluconazole or voriconazole exhibited indifferent interactions. No antagonism was observed for any combination.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  Candida auris; azoles; echinocandins; in vitro interactions

Mesh：

Substances：

Year:  2017        PMID： 28848002      PMCID： PMC5655075          DOI： 10.1128/AAC.01056-17

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  32 in total

1.  Can Multidrug-Resistant Candida auris Be Reliably Identified in Clinical Microbiology Laboratories?

Authors:  Masako Mizusawa; Heather Miller; Rachel Green; Richard Lee; Mariann Durante; Rosalie Perkins; Caroline Hewitt; Patricia J Simner; Karen C Carroll; Randall T Hayden; Sean X Zhang
Journal:  J Clin Microbiol       Date:  2016-11-23       Impact factor: 5.948

2.  ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.

Authors:  O A Cornely; M Bassetti; T Calandra; J Garbino; B J Kullberg; O Lortholary; W Meersseman; M Akova; M C Arendrup; S Arikan-Akdagli; J Bille; E Castagnola; M Cuenca-Estrella; J P Donnelly; A H Groll; R Herbrecht; W W Hope; H E Jensen; C Lass-Flörl; G Petrikkos; M D Richardson; E Roilides; P E Verweij; C Viscoli; A J Ullmann
Journal:  Clin Microbiol Infect       Date:  2012-12       Impact factor: 8.067

3.  Comparative effects of micafungin, caspofungin, and anidulafungin against a difficult-to-treat fungal opportunistic pathogen, Candida glabrata.

Authors:  Elisabetta Spreghini; Fiorenza Orlando; Maurizio Sanguinetti; Brunella Posteraro; Daniele Giannini; Esther Manso; Francesco Barchiesi
Journal:  Antimicrob Agents Chemother       Date:  2011-12-27       Impact factor: 5.191

4.  Candida auris candidaemia in Indian ICUs: analysis of risk factors.

Authors:  Shivaprakash M Rudramurthy; Arunaloke Chakrabarti; Raees A Paul; Prashant Sood; Harsimran Kaur; Malini R Capoor; Anupma J Kindo; Rungmei S K Marak; Anita Arora; Raman Sardana; Shukla Das; Deepinder Chhina; Atul Patel; Immaculata Xess; Bansidhar Tarai; Pankaj Singh; Anup Ghosh
Journal:  J Antimicrob Chemother       Date:  2017-06-01       Impact factor: 5.790

5.  In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance.

Authors:  M A Pfaller; L Boyken; R J Hollis; J Kroeger; S A Messer; S Tendolkar; D J Diekema
Journal:  J Clin Microbiol       Date:  2007-11-21       Impact factor: 5.948

6.  Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geographic and temporal trends of antifungal resistance.

Authors:  Michael A Pfaller; Shawn A Messer; Leah N Woosley; Ronald N Jones; Mariana Castanheira
Journal:  J Clin Microbiol       Date:  2013-05-29       Impact factor: 5.948

7.  First hospital outbreak of the globally emerging Candida auris in a European hospital.

Authors:  Silke Schelenz; Ferry Hagen; Johanna L Rhodes; Alireza Abdolrasouli; Anuradha Chowdhary; Anne Hall; Lisa Ryan; Joanne Shackleton; Richard Trimlett; Jacques F Meis; Darius Armstrong-James; Matthew C Fisher
Journal:  Antimicrob Resist Infect Control       Date:  2016-10-19       Impact factor: 4.887

8.  Echinocandin Resistance in Candida Species Isolates from Liver Transplant Recipients.

Authors:  Gwénolé Prigent; Nawel Aït-Ammar; Eric Levesque; Arnaud Fekkar; Jean-Marc Costa; Sarra El Anbassi; Françoise Foulet; Christophe Duvoux; Jean-Claude Merle; Eric Dannaoui; Françoise Botterel
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

9.  The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation.

Authors:  Emily Larkin; Christopher Hager; Jyotsna Chandra; Pranab K Mukherjee; Mauricio Retuerto; Iman Salem; Lisa Long; Nancy Isham; Laura Kovanda; Katyna Borroto-Esoda; Steve Wring; David Angulo; Mahmoud Ghannoum
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

10.  Multidrug-Resistant Candida haemulonii and C. auris, Tel Aviv, Israel.

Authors:  Ronen Ben-Ami; Judith Berman; Ana Novikov; Edna Bash; Yael Shachor-Meyouhas; Shiri Zakin; Yasmin Maor; Jalal Tarabia; Vered Schechner; Amos Adler; Talya Finn
Journal:  Emerg Infect Dis       Date:  2017-02       Impact factor: 6.883
View more
  26 in total

Review 1.  Candida auris: a Review of the Literature.

Authors:  Anna Jeffery-Smith; Surabhi K Taori; Silke Schelenz; Katie Jeffery; Elizabeth M Johnson; Andrew Borman; Rohini Manuel; Colin S Brown
Journal:  Clin Microbiol Rev       Date:  2017-11-15       Impact factor: 26.132

2.  Laboratory Analysis of an Outbreak of Candida auris in New York from 2016 to 2018: Impact and Lessons Learned.

Authors:  YanChun Zhu; Brittany O'Brien; Lynn Leach; Alexandra Clarke; Marian Bates; Eleanor Adams; Belinda Ostrowsky; Monica Quinn; Elizabeth Dufort; Karen Southwick; Richard Erazo; Valerie B Haley; Coralie Bucher; Vishnu Chaturvedi; Ronald J Limberger; Debra Blog; Emily Lutterloh; Sudha Chaturvedi
Journal:  J Clin Microbiol       Date:  2020-03-25       Impact factor: 5.948

3.  In vitro antifungal combination of flucytosine with amphotericin B, voriconazole, or micafungin against Candida auris shows no antagonism.

Authors:  A L Bidaud; F Botterel; A Chowdhary; E Dannaoui
Journal:  Antimicrob Agents Chemother       Date:  2019-10-07       Impact factor: 5.191

4.  Candida auris Clinical Isolates from South Korea: Identification, Antifungal Susceptibility, and Genotyping.

Authors:  Yong Jun Kwon; Jong Hee Shin; Seung A Byun; Min Ji Choi; Eun Jeong Won; Dain Lee; Seung Yeob Lee; Sejong Chun; Jun Hyung Lee; Hyun Jung Choi; Seung Jung Kee; Soo Hyun Kim; Myung Geun Shin
Journal:  J Clin Microbiol       Date:  2019-03-28       Impact factor: 5.948

Review 5.  Emerging and future strategies in the management of recalcitrant Candida auris.

Authors:  Nihal Bandara; Lakshman Samaranayake
Journal:  Med Mycol       Date:  2022-03-17       Impact factor: 4.076

6.  Evaluation of a new matrix-assisted laser desorption/ionization time-of-flight mass spectrometry system for the identification of yeast isolation.

Authors:  Hyeyoung Lee; Ji-Hyun Park; Junsang Oh; Sungil Cho; Jehyun Koo; Ik Chun Park; Jiwoo Kim; Sehyun Park; Ji Seon Choi; So Youn Shin; Gi-Ho Sung; Jayoung Kim
Journal:  J Clin Lab Anal       Date:  2018-10-08       Impact factor: 2.352

7.  The efflux pump inhibitor tetrandrine exhibits synergism with fluconazole or voriconazole against Candida parapsilosis.

Authors:  Ya-Jing Zhao; Wei-Da Liu; Yong-Nian Shen; Dong-Mei Li; Kun-Ju Zhu; Hong Zhang
Journal:  Mol Biol Rep       Date:  2019-08-12       Impact factor: 2.316

8.  In vitro and in vivo interaction of caspofungin with isavuconazole against Candida auris planktonic cells and biofilms.

Authors:  Fruzsina Nagy; Zoltán Tóth; Fanni Nyikos; Lajos Forgács; Ágnes Jakab; Andrew M Borman; László Majoros; Renátó Kovács
Journal:  Med Mycol       Date:  2021-10-04       Impact factor: 4.076

9.  Evaluation of Synergistic Activity of Isavuconazole or Voriconazole plus Anidulafungin and the Occurrence and Genetic Characterization of Candida auris Detected in a Surveillance Program.

Authors:  Michael A Pfaller; Shawn A Messer; Lalitagauri M Deshpande; Paul R Rhomberg; Eric A Utt; Mariana Castanheira
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.191

10.  Azole-resistant Aspergillus and Echinocandin-resistant Candida - What are the treatment options?

Authors:  Alison R Novak; Mary E Bradley; Tyree H Kiser; Scott W Mueller
Journal:  Curr Fungal Infect Rep       Date:  2020-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.